Cara,
An airline is worth a lot more than $250,000.
Also-
The difference between operating and development stage is minimal in their market cap. They could launch operations, have terrible financial performance and the markets would reward them accordingly.
It's the same reason why biotech companies can have largely inflated market caps with no product versus established pharmaceuticals. The "buzz" of their pipleine drug products creates more of a value than a company with an actual product.
And, Viva really needs to get themselves off the OTB trading. Pink slips isn't a credible market and for the most part they'll get penny stock traders, not the institutional investors and awareness they'll need to build a bigger market cap.
If the market cap is really just $2 million, I'd take the company private. Launch operations, build a steady business plan and strong financial performance and then take the company public again. Being publicly-traded adds a lot of weight and overhead that a small company shouldn't be focusing on.
These are just my two cents, though.